Philip Morris
Law Concerning Medical Devices Is Often Ignored
Fields
- Author
- Burton, T.M.
- Area
- NICOLI,DAVID/OFFICE
- Type
- NEWS, NEWS ARTICLE
- Site
- W6
- Request
- Stmn/R1-072
- Stmn/R1-079
- Named Organization
- Cardiac Pacemakers
- Co Dept of Health
- Congress
- Cr Bard
- Eli Lilly
- FDA, Food and Drug Administration
- General Accounting Office
- Aequitron Medical
- Co Dept of Health
- Named Person
- Benesch, B.H.
- Dingell, J.
- Finzen, B.A.
- Kessler, D.
- Dingell, J.
- Document File
- 2046936725/2046937271/Missing
- Litigation
- Stmn/Produced
- Author (Organization)
- Wall Street Journal
- Master ID
- 2046936726/6992
Related Documents:- 2046936726 Table of Contents
- 2046936727 A
- 2046936728-6731 FDA's Legally Suspect Actions Invite Challenge
- 2046936732-6735 FDA Paralysis Raises Health Care Costs
- 2046936736-6739 the Real Problem with Health Care in America: While Dr. David Kessler's FDA Fiddles, Medical Approvals Lag and Americans Die
- 2046936740-6743 What the FDA Doesn't Want You to Know Could Kill You
- 2046936744-6751
- 2046936752-6759
- 2046936760-6762 Guide to Medical Device Regulation FDA Issues First Warning Letter Citing Gmp Problems Under New Cpg
- 2046936763-6766 the Vitamin Uprising
- 2046936767-6780 Losing the Edge Overseas Patients Reap the Benefits of U.S.Research While Those Here Wait
- 2046936781-6783 Losing the Edge
- 2046936784 Feds: Toughen Regulation, Promote Research Improvements Needed, and They Are on the Way
- 2046936785-6786
- 2046936787-6789 Challenging FDA Authority
- 2046936790-6793 Speakeasies in A New Age of Prohibition
- 2046936794-6798 Who Is Happiest Politician in Washington Over Whitewater? Alfonse D'amato - Newt Gingrich - David Kessler?
- 2046936799-6800 Pro-Free Enterprise Group Challenges FDA's Authority to Regulate Drug Companies' Speech
- 2046936801-6802 Wlf Off-Label Use Suit Heats Up
- 2046936803-6805 Just Call Me 'doc'
- 2046936806-6810 Food and Drugs and Politics
- 2046936811-6813 Science and Technology Getting the Lead Out
- 2046936814 Forbes Fear of Falling 5 Ways to Protect Yourself in Scary Times
- 2046936815-6816 Book Burning
- 2046936817 If A Murderer Kills You, It's Homicide If A Drunk Driver Kills You, It's Manslaughter If the FDA Kills You, It's Just Being Cautious
- 2046936818-6820 Frustration for Medical Innovators
- 2046936821 Block That Innovation
- 2046936822-6823 Getting Even
- 2046936824-6826 Biotech Pipeline: Bottleneck Ahead
- 2046936827-6829 Consuming Interest Are We Safe From the FDA?
- 2046936830-6839 Saying Yes to Drugs Policy Analysis
- 2046936840-6858 Deadly Overcaution: FDA's Drug Approval Process
- 2046936859 B
- 2046936860-6861 Litigation Update Wlf Wins Suit Against FDA to Stop Overregulation of Heart Valves (Washington Legal Foundation V. Shalala)
- 2046936862-6863 Litigation Update Wlf Opposes FDA Efforts to Dismiss First Amendment Lawsuit (Washington Legal Foundation V. Kessler)
- 2046936864-6867 Dickinson's FDA Review
- 2046936868-6869 Wlf Urges Appeals Court to Enjoin Federal Policy Restricting Human Heart Valve Transplant (Washington Legal Foundation V. Shalala)
- 2046936870-6871 FDA Problems Slow US Andas
- 2046936872-6873 Taking the Heat An Aids Patient Champions A Risky Blood Treatment Banned in the U.S.
- 2046936874-6876 New Study Says Breast Implants Are Not A Health Risk
- 2046936877-6878 Wlf Sues FDA to Overturn Policy Restricting Information on Off-Labels Uses of Approved Drugs and Devices (Washington Legal Foundation V. Shalala)
- 2046936879 Ex-Inspector of F.D.A. Is Convicted of Bribery
- 2046936879A FDA Has No Position Yet
- 2046936880-6881 M-D-D-I Reports - 'the Gray Sheet'
- 2046936882 FDA Halts Test on Device That Shows Promise for the Victims of Cardiac Arrest
- 2046936884 Dairies, Drugs and Accusations
- 2046936884A FDA to Launch Campaign on New Labels for Food
- 2046936885 Probe of Three FDA Officials Sought Industry Ties Before Approval of Bovine Growth Hormone Are at Issue
- 2046936886-6889 Safety First How A Device to Aid in Breast Self-Exams If Kept Off the Market Other Nations Approved It But U.S. Demands Proof Simple Pad Isn't Risky Nine Year Battle with the FDA
- 2046936890-6892 Who Will Regulate the Regulators? If You Make A Mistake, Shouldn't You Own Up? Not If You're the FDA, Epa, or Ftc
- 2046936893-6894 None - A - Day Is the FDA Out to Take Your Vitamin?
- 2046936895 Will A New Government Program Net the Bad Fish?
- 2046936896-6897 FDA Responds to Wlf Petition Regarding Off-Label Drug Use by Indefinitely Postponing Issuance of Regulatory Guidelines
- 2046936898-6905 FDA Research: Overview
- 2046936906-6910 Government Report Finds Levels Safe Pesticide Residues in Your Children's Food
- 2046936911-6912 Wlf Urges FDA to Rescind Policy Restricting Information Flow on Off-Label Uses of Approved Drugs and Devices
- 2046936913 Regulatory Chokehold FDA Red Tape Dooms Transplant Drug
- 2046936914 FDA Called Lax in Overseeing Medical Sterilizers, Disinfectants
- 2046936915 FDA Sets Labeling Rules for Dietary Supplements Nutritional Data, Support for Health Claims Required
- 2046936916 Chemicals That Taint Seafood Concerns Continue Over Safety of Methylmercury Inspection Processes
- 2046936917 Lifesaving Devices Languish at the FDA
- 2046936918-6919 Wlf Sues FDA to Enjoin Federal Policy Restricting Human Heart Valve Transplants (Washington Legal Foundation V. Shalala)
- 2046936920 What's in Food? Answers Differ at 2 Agencies Manufacturers Fight to Keep FDA Label Rules From Encroaching on Ftc Ad Rules
- 2046936921 Reform the FDA
- 2046936922 Legal Beat FDA Approval Shield Firms in Injury Suits
- 2046936923 Water From A Bottle
- 2046936924 Commentary FDA and Our Split Medical Persona
- 2046936925-6926 FDA Assailed for Slow Testing of New Drugs
- 2046936927 Andrews Office Products Capitol Heights, Md (K)
- 2046936928-6947 Statement by David A. Kessler, M.D. Commissioner of Food and Drugs Before the Committee on Energy and Commerce Subcommittee on Health and the Environment U.S. House of Representatives
- 2046936948-6961 Filthy Food,Dubious Drugs, and Defective Devices: the Legacy of FDA's Antiquated Statute A Staff Report
- 2046936962-6968 Gao Reports on FDA-Related Topics 860000 to Present
- 2046936969 D
- 2046936970-6985 Statement by Louis W. Sullivan, M.D. Secretary of Health and Human Services Before the Committee on Labor and Human Resources U.S. Senate on the Final Report of the Advisory Committee on the FDA
- 2046936986-6992 Proposed Remarks of Dr. Charles Edwards Before the Senate Committee on Labor and Human Resources
- Characteristic
- MARG, MARGINALIA
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- hnn65e00
Document Images
HEALTH
Law Concerning
~ Medical Devices
Is Often Ignored
By THOMas M. BoxTOv
StaJJReporter of Tx Wwt.t. Srnt:eT JOURNAL
Although hospitals and doctors are le-
gally required to disclose malfunctions of
heart valves, wheelchair lifts and other
medical equipment, in fact, many don't.
More than three years after the pas-
sage of the Safe Medical Devices Act, the
Food and Dru Administration still hasn't
is ue a regulation c ar ing which
health-care providers have to disclose
what information. "The lack of a final
regulation has caused a great deal of
confusion," acknowledges Bryan H. Ben-
esch, an FDA official who helps oversee
enforcement of the medical-device report-
ing laws. "Many people just don't under-
stand what they're supposed to do." Says
another FDA official, "We're aware that
people will thumb their noses at us until
there is a regulation."
Manufacturers of medical devices have
been required to report problems with
medical devices since 1985. But scores of
them haven't done it. In the late 1980s,
dozens of babies hooked up to "apnea"
monitors, which sense breathing and
~ heartbeats, died in their sleep, including
cases in which the monitors reportedly
failed to sound an alarm. One manufac-
turer, Aequitron Medical Inc. of Minneapo-
lis, didn't notify the FDA of more than 50
deaths, according to congressional testi-
mony; Aequitron says it has since re-
vamped its machines and reporting pol-
icy.
Between 1988 and 1991, FDA inspectors
found that 65 companies hadn't reported
serious incidents. The agency says compa-
nies failing to report included indus-
try leaders like C.R. Bard Inc., which
didn't report 229 incidents involving its
cardiac angioplasty catheters, and Eli
Lilly. & Co.'s Cardiac Pacemakers Inc.
unit, which didn't disclose more than 600
patient problems related to its insulin
infusion pump. Bard declines to comment.
Cardiac Pacemakers, which discontinued
sale of the pump, says it hadn't believed
the incidents needed to be reported.
Because the manufacturers couldn't be
counted on to report problems with their
devices, the new law, passed in 1990, put
additional responsibility for reporting in
the hands of hospitals and doctors. But in
February, the General Accounting Office,
Congress's investigative arm, said in a
letter to Rep. John Dingeil that the FDA
had found evidence that hospitals and
~ther health providers were largely disre
garding the law.
For example, the Colorado Department
of Health reported to the FDA that it visited
175 health-care facilities and found that
only 36% of them were fully complying and
that only 26% of personnel understood what
Please Tunt to Page B6, Column 1
Law on Medical Device Problems
Is Frequently Ignored by Hospitals
Continued Fronc Page BI
the law requires. In Texas, about 45% of the
175 facilities surveyed were~ aware of the
act, and 35% of them had written proce-
dures telling staffers specifically what to
do. Only in a Massachusetts survey did
compliance seem better, with 72% of the
118 facilities surveyed being aware of the
act's reporting requirements.
Reporting problems is often the only
early warning signal that something is
wrong with a medical device. Because
many devices have been grandfathered
onto the market, they have not undergone
rigorous scrutiny. Breast implants are a
well-known example. They have been ten-
tatively linked to immune-system illnesses
and definitively linked to painful and dis-
figuring conditions, including open sores
through which silicone seeps out.
When FDA inspectors making routine
visits turn up evidence that companies
have failed to make required disclosures,
the agency responds with warning letters
Wall St. Jnl
Washington, DC
MAY 7 i 1gq~
and other regulatory sanctions, says FDA
Commissioner David Kessler, who believes
these measures are improving compliance
with the reporting law. The total number of
reports of malfunctions and related deaths
and injuries jumped to 88,265 by 1993 from
27,883 in 1990.
Even so, FDA officials believe there is
still underreporting - "the magnitude ...
is anybody's guess," Mr. Benesch says.
When manufacturers do file reports, he
adds, there often is no corresponding re-
~
port filed by a hospital.
The underreporting by manufacturers
was especially egregious in the first few
years of the law. In a December 1986
survey of hospitals, the GAO concluded
that 99,70 of problems associated with cer-
tain selected medical devices weren't re-
ported. ----
To Bruce A. Finzen, a Minneapolis
products-liability lawyer, congressional
attempts to fix problems like underreport-
ing just aren't very effective. "The device-
reporting law just sits there," he says. ~'
